By Debi Wimberley, Certified Cannabis Specialist and Founder of the Effective Cannabis Newsletter

You were born with a sophisticated biological system designed to manage pain, inflammation, mood, and the healing process, the Endocannabinoid System (ECS) [1]. Yet chances are your doctor has never mentioned it. Medical Cannabis pain relief works through this system. Still, patients worldwide continue to suffer needlessly while healthcare systematically ignores decades of research showing Cannabis as effective, safer pain relief compared to opioids.

The real "one-off" isn't whether Cannabis works for pain—it's that we're actively denying relief despite overwhelming evidence.

Cannabis Pain Relief Research: The Evidence Hiding in Plain Sight

For more than 25 years, the science has been clear. Yet we keep pretending it isn't.

In 1999, the prestigious Institute of Medicine published a landmark report concluding that "cannabinoids likely have a natural role in pain modulation" and that Cannabis was effective for pain, nausea, and spasticity [2]. The report recognized that "people vary in their responses to medications, and there will likely always be a subpopulation of patients" who could benefit from Cannabis when other treatments fail [2].
That was a quarter-century ago.
Since then, the evidence has only grown stronger. A 2017 National Academies report found "conclusive or substantial evidence that Cannabis or cannabinoids are effective for the treatment of pain in adults" [3]. The Mayo Clinic's 2025 comprehensive review confirms Cannabis as a "promising alternative for pain management, leveraging interaction with the Endocannabinoid System" [4].

Breaking News: October 2025 brought game-changing Phase 3 clinical trial results

VER-01, a standardized full-spectrum Cannabis extract, demonstrated superior pain relief compared to opioids in treating chronic low back pain with better gastrointestinal tolerability and no evidence of dependence or abuse [5,6]. Published in Nature Medicine, the study of 820 participants found VER-01 reduced pain scores by 1.9 points versus 1.4 for placebo, with improvements in sleep quality and physical function lasting through 18 months of treatment [5].

Real-world data backs this up: New York State studied 8,000+ patients and found 47-51% opioid reduction after just eight months of medical Cannabis use [7]. Multiple studies report 64% reduction in opioid use when chronic pain patients have access to Cannabis [8]. Systematic reviews spanning thousands of patients consistently show significant Cannabis pain relief for chronic pain [9].

Yet walk into most doctors' offices, and they'll still tell you, "We need more research."

We don't need more research. We need more courage.

How the Endocannabinoid System Relieves Pain

Every human possesses cannabinoid receptors CB1 and CB2, part of that same Endocannabinoid System you were born with to manage pain, inflammation, and healing. CB1 receptors in your brain and nervous system act as "gatekeepers" controlling pain signals. Your body naturally produces compounds, such as anandamide (Sanskrit for "bliss"), that bind to these receptors, regulating pain, mood, inflammation, and healing [10].

This isn't alternative medicine. This is human biology.

Medical Cannabis works because it activates the same system your body uses naturally to:

• Block pain signals through "modulation of neuronal activity in the CNS and the periphery" [4]
• Reduce inflammation through immune cell regulation [4]
• Enhance your body's own healing responses
• Provide comprehensive symptom relief that single-target drugs can't match

Yet this fundamental biological system, discovered in 1988, remains absent from most medical school curricula. How can doctors treat what they don't understand?

The Education Emergency: What Doctors Aren't Taught About Pain and Safety

Medical schools spend countless hours teaching about opioid pharmacology. Yet most physicians graduate without learning about the Endocannabinoid System, one of the body's largest neurotransmitter networks. This knowledge gap has profound consequences for patients seeking safe, effective pain relief.

Medical Cannabis has zero recorded fatal overdoses in thousands of years of documented use [11]. Opioids, by contrast, kill over 70,000 Americans annually [11]. Research confirms Cannabis is "one of the least physiologically toxic analgesics, with a very high therapeutic index" [12], meaning the gap between therapeutic and toxic doses is exceptionally wide.

The October 2025 VER-01 Phase 3 trials make the contrast even starker. In a head-to-head comparison with opioids, the Cannabis-based treatment showed superior pain relief and better gastrointestinal tolerability, with 83% of VER-01 patients experiencing only mild-to-moderate side effects versus the serious risks of opioid therapy [6]. Most importantly, VER-01 showed no signs of dependence, abuse, or withdrawal symptoms, unlike opioids, where 20% of long-term users develop opioid use disorder [6].

Unlike opioids, Cannabis doesn't suppress breathing because cannabinoid receptors are absent from brainstem respiratory centers [12]. Compare that to opioids: respiratory depression occurs in 1.9% to 83.4% of patients depending on risk factors [13], along with addiction, overdose, and death.

The Healthcare System systematically prescribes more dangerous drugs while denying safer alternatives.

The education gap isn't just about safety; it's about missing an entire biological system that could help millions. Most doctors can't explain how the ECS works, don't know about CB1 and CB2 receptors, and have never heard of anandamide or 2-AG. They're treating chronic pain and other conditions with incomplete knowledge of the body’s natural pain management system.

Which sounds like evidence-based medicine to you?

Medical Cannabis Applications for Chronic Pain and Beyond

Substantial research supports Cannabis pain relief and cannabinoid therapy for a variety of conditions:

• Chronic neuropathic pain: Mayo Clinic confirms medical Cannabis is "particularly effective for easing chronic pain, especially pain caused by nerve damage" [14]
• Cancer-related pain: Evidence suggests Cannabis helps with "pain, nausea and recovery from severe weight loss" in cancer patients [15]
• Multiple sclerosis spasticity: Cannabis has been "shown to be useful in relieving painful muscle spasms caused by conditions such as multiple sclerosis or spinal cord injuries" [14]
• Inflammatory conditions: Arthritis, IBD, and autoimmune disorders [16]
• PTSD and anxiety disorders: Especially in veterans and trauma survivors [17]

Many of these patients have a condition called Clinical Endocannabinoid Deficiency; their bodies don't produce enough endocannabinoids [16]. It's similar to insulin deficiency in diabetes, yet we're not addressing the underlying biological deficit. By supporting the Endocannabinoid System, Cannabis therapies can restore balance and provide meaningful relief for patients with chronic pain and other ECS-related conditions. 

 

Patient Testimonials: Cannabis Pain Relief Success Stories

Since May 2023, the Effective Cannabis Newsletter has been systematically documenting patient outcomes. This isn't anecdotal; this is real-world evidence tracking showing consistent results across diverse patient populations and pain conditions.

The Numbers Tell the Story

From our snapshot analysis of 40+ documented testimonials:

Medication Replacement Results:

• 67% completely replaced opioid medications with Cannabis. Read read Tricia's opioid-free journey
• 100% reduced or eliminated other pain medications (NSAIDs, muscle relaxers) see see William's transformation
• Average of 3-5 medications eliminated per patient
• 100% reported symptom relief improvements
• Zero patients reported returning to previous medications read Sandy's remission story

Demographics & Conditions:

• Age range: 36-72 years (median age 54)
• Conditions treated: Chronic pain, fibromyalgia, neuropathy, arthritis, cancer pain, MS, lupus, spinal injuries, PTSD, anxiety
• Previous failed treatments: Average of 5+ conventional treatments before Cannabis
• Time to relief: 60% experienced improvement within 30 days

The Pattern Is Clear:

When patients overcome barriers to access Cannabis pain relief,

• Side effects are minimal compared to conventional treatments
• Patients report engagement in activities previously impossible

This real-world evidence underscores that cannabinoid therapy works with the Endocannabinoid System to provide safe, effective relief for chronic pain and other challenging conditions.

Healthcare's Willful Blindness to Cannabis Pain Management Evidence

To Healthcare Professionals: You demand evidence-based medicine, yet continue to dismiss both the science and the patients living it. As well as the role of the Endocannabinoid System (ECS) in pain management and healing. Too many people in chronic pain are left to suffer, not because options don’t exist but because Cannabis pain relief is still treated as taboo instead of therapy.

Instead of exploring medical Cannabis pain as a safe, evidence-based option, many healthcare providers still dismiss patients’ questions and concerns. Each time a patient asks about Cannabinoid therapy or Cannabis for pain and is told it’s “not proven” or "harmful," they are denied access to safer, more effective treatment. This isn’t a lack of research. It’s a lack of recognition of the Endocannabinoid System and its role in chronic pain management. Your patients are suffering while you debate settled science.

Every dismissed conversation leaves another patient with dangerous alternatives. The Hippocratic Oath demands you "first, do no harm." How is denying safer alternatives upholding that principle?
Research shows "CB1 agonists, including THC, are the key components to the analgesic effects seen through modulation of neuronal activity within the Endocannabinoid System. The mechanisms are well-understood and supported by decades of medical Cannabis research.

Cannabis isn't "alternative medicine"—it's ignored medicine.

 Understanding Your Endocannabinoid System and Pain Relief Options

You have the right to evidence-based care. That includes discussions about the Endocannabinoid System and Cannabinoid therapy for chronic pain. Don't accept "we don't know enough" when thousands of studies already show Cannabis pain relief is effective and safe.

Your ECS plays a critical role in regulating pain perception, inflammatory responses, sleep cycles, mood regulation, appetite, digestive function, immune system balance, healing, memory, and stress responses. Understanding this system empowers you to make informed decisions about your pain management and overall wellness. Just as you learned about your cardiovascular or digestive systems, you deserve to understand the biological network that governs pain, healing, and homeostasis.

Ask your healthcare provider these questions:

• What do you know about the Endocannabinoid System?
  
• Have you reviewed the Mayo Clinic's Cannabis pain research?
• Why aren't we exploring cannabinoid therapy?
• Can you refer me to a clinician educated in Cannabis medicine?

If they can't answer, find someone who can.

Educational Resources:

• Search "endocannabinoid system" on PubMed for peer-reviewed research
• Subscribe to the Effective Cannabis Newsletter for monthly research updates, firsthand stories, articles, videos, podcasts, for vetted education you can share with your healthcare provider
• Connect with healthcare providers, certified educators, and coaches trained in cannabinoid medicine
• Demand that ECS education be included in medical school curricula

Why Cannabis Should Be First-Line Pain Treatment

Every human has an Endocannabinoid System. Every person deserves access to therapies that work with their biology, not against it. We're witnessing a systematic denial of evidence-based medicine while people suffer.

This isn't about Cannabis culture or politics. It's about human suffering and scientific integrity.

The evidence is overwhelming. The need is urgent. The time for denial is over.

Healthcare providers: Learn about the ECS. Review the research. Have honest conversations with patients. Your oath demands it.

Patients and families: Demand better. Ask questions. Seek second opinions. Your health depends on it.

Everyone: Share this information. Support research funding. Contact legislators. The ECS belongs in medical education, and evidence-based medicine must include ALL the evidence.

We must stop leaving people to suffer while we ignore the science that could heal them. The most significant "one-off" in modern medicine isn't that Cannabis doesn't work, it's that we're pretending it doesn't when all the evidence says otherwise.

Your Endocannabinoid System is waiting. Isn't it time your healthcare team caught up?

 Have you experienced relief with medical Cannabis? We want to hear from you share your Cannabis relief success story and help others understand what's possible. For more information and patient testimonials, visit the Effective Cannabis Newsletter or contact us at [email protected].

References

1. Grinspoon, Peter. “The Endocannabinoid System: Essential and Mysterious by Dr. Grinspoon.” The Endocannabinoid System: Essential and Mysterious by Dr. Grinspoon, 28 Dec. 2022.

2. Institute of Medicine (1999). "Marijuana and Medicine: Assessing the Science Base." National Academies Press. https://nap.nationalacademies.org/read/6376/chapter/2

3. National Academies of Sciences, Engineering, and Medicine (2017). "The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research." https://nap.nationalacademies.org/catalog/24625/

4. Johnson Brooks et al. (2025). "Cannabinoids in Chronic Pain Management: A Review of the History, Efficacy, Applications, and Risks." Mayo Clinic Proceedings. PMC11940634. https://pmc.ncbi.nlm.nih.gov/articles/PMC11940634/

5. Karst M, Meissner W, et al. (2025). "Full-spectrum extract from Cannabis sativa DKJ127 for chronic low back pain: a phase 3 randomized placebo-controlled trial." Nature Medicine. Published September 29, 2025. https://www.nature.com/articles/s41591-025-03977-0

6. Meissner W, Argoff C, et al. (2025). "VER-01 shows enhanced gastrointestinal tolerability, superior pain relief, and improved sleep quality compared to opioids in treating chronic low back pain: a randomized phase 3 clinical trial." Pain & Therapy. Published September 30, 2025. doi:10.1007/s40122-025-00773-z https://link.springer.com/article/10.1007/s40122-025-00773-z

7. New York State Department of Health (2023). "Multi-Agency Study: Changes in Prescribed Opioid Dosages Among Patients Receiving Medical Cannabis for Chronic Pain, New York State, 2017-2019." Published in JAMA Network Open. https://health.ny.gov/press/releases/2023/2023-01-31_jamma.htm

8. StatPearls (2025). "Medicinal Cannabis for Treatment of Chronic Pain." NCBI Bookshelf. https://www.ncbi.nlm.nih.gov/books/NBK574562/

9. Whiting PF et al. (2015). "Cannabinoids for Medical Use: A Systematic Review and Meta-analysis." JAMA Network. https://jamanetwork.com/journals/jama/fullarticle/2338251

10. Mayo Clinic Proceedings (2018). "Medical Cannabis." https://www.mayoclinicproceedings.org/article/S0025-6196(18)30709-2/fulltext

11. StatPearls (2025). "Opioid Toxicity." NCBI Bookshelf. https://www.ncbi.nlm.nih.gov/books/NBK470415/

12. Knerich V et al. (2021). "Practical Strategies Using Medical Cannabis to Reduce Harms Associated With Long Term Opioid Use in Chronic Pain." Frontiers in Pharmacology. https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2021.633168/full

13. Zedler B et al. (2019). "Prevention of Opioid Overdose." New England Journal of Medicine. https://www.nejm.org/doi/full/10.1056/NEJMra1807054

14. Mayo Clinic Q&A (2018). "Treatment with Medical Cannabis." Mayo Clinic News Network. https://newsnetwork.mayoclinic.org/discussion/mayo-clinic-q-and-a-treatment-with-medical-cannabis/

15. Mayo Clinic Press (2023). "Conversations with the Experts: Cannabis 101." https://mcpress.mayoclinic.org/living-well/conversations-with-the-experts-cannabis-101/

16. Russo EB. (2016). "Clinical Endocannabinoid Deficiency Reconsidered: Current Research Supports the Theory in Migraine, Fibromyalgia, Irritable Bowel, and Other Treatment-Resistant Syndromes." Cannabis and Cannabinoid Research. PMC5576607. https://pmc.ncbi.nlm.nih.gov/articles/PMC5576607/

17. Lucas P. (2017). "Rationale for cannabis-based interventions in the opioid overdose crisis." Harm Reduction Journal. https://harmreductionjournal.biomedcentral.com/articles/10.1186/s12954-017-0183-9

All links accessed and verified as of October 2025. For complete patient testimonials and additional supporting content, sign up to receive the Effective Cannabis Newsletter

About Debi Wimberley:

Debi Wimberley is a resilient advocate for Medical Cannabis education and self-empowered health. A survivor of decades of chronic pain and lung disease, she turned her background in medical technology, oncology, and hospital systems into tools for thriving. Certified in Medical Cannabis applications and Patient Care, Debi is a professional communicator, podcaster, TEDx speaker, and author. Founder of Effective Cannabis and Effective Cannabis Newsletter. Her mission is to centralize quality, accurate, fact-based education through collaborative work with other certified Cannabis educators, health coaches, and professionals.

Click the Learn More Button 

Effective Cannabis Newsletter is a platform to educate on the vital role of the Endocannabinoid System (ECS) in one's health. The information is not intended or implied to be a substitute for professional medical advice, diagnosis, or treatment. All content, including text, graphics, images, and information, contained in or available through this newsletter is for general information purposes only. It is not medical advice; it is health awareness.